22q11.2 deletion syndrome (22q11.2DS) is the most common microdeletion syndrome in humans. Survival to reproductive age and beyond is now the norm. Several manifestations of this syndrome, such as congenital cardiac disease and neuropsychiatric disorders, may increase risk for adverse pregnancy outcomes in the general population. However, there are limited data on reproductive health in 22q11.2DS. We performed a retrospective chart review for 158 adults with 22q11.2DS (75 male, 83 female; mean age 34.3 years) and extracted key variables relevant to pregnancy and reproductive health. We present four illustrative cases as brief vignettes. There were 25 adults (21 > age 35 years; 21 female) with a history of one or more pregnancies. Outcomes for women with 22q11.2DS, compared with expectations for the general population, showed a significantly elevated prevalence of small for gestational age liveborn offspring (p < 0.001), associated mainly with infants with 22q11.2DS. Stillbirths also showed elevated prevalence (p < 0.05). Not all observed adverse events appeared to be attributable to transmission of the 22q11.2 deletion. Recurring issues relevant to reproductive health in 22q11.2DS included the potential impact of maternal morbidities, inadequate social support, unsafe sexual practices, and delayed diagnosis of 22q11.2DS and/or lack of genetic counseling. These preliminary results emphasize the importance of early diagnosis and long term follow-up that could help facilitate genetic counseling for men and women with 22q11.2DS. We propose initial recommendations for pre-conception management, educational strategies, prenatal planning, and preparation for possible high-risk pregnancy and/or delivery.
This is a preview of subscription content, access via your institution.
Angkustsiri, K., Goodlin-Jones, B., Deprey, L., Brahmbhatt, K., Harris, S., & Simon, T. (2014). Social impairments in chromosome 22q11.2 deletion syndrome (22q11.2DS): autism spectrum disorder or a different endophenotype? Journal of Autism and Developmental Disorders, 44(4), 739–746.
Bassett, A. S., & Chow, E. W. (2008). Schizophrenia and 22q11.2 deletion syndrome. Current Psychiatry Reports, 10(2), 148–157.
Bassett, A. S., Chow, E. W., Husted, J., Weksberg, R., Caluseriu, O., Webb, G. D., et al. (2005). Clinical features of 78 adults with 22q11 deletion syndrome. American Journal of Medical Genetics Part A, 138(4), 307–313.
Bassett, A. S., Marshall, C. R., Lionel, A. C., Chow, E. W., & Scherer, S. W. (2008). Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Human Molecular Genetics, 17(24), 4045–4053.
Bassett, A. S., Chow, E. W., Husted, J., Hodgkinson, K. A., Oechslin, E., Harris, L., et al. (2009). Premature death in adults with 22q11.2 deletion syndrome. Journal of Medical Genetics, 46(5), 324–330.
Bassett, A. S., McDonald-McGinn, D. M., Devriendt, K., Digilio, M. C., Goldenberg, P., Habel, A., et al. (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. Journal of Pediatrics, 159(2), 332–339 e331.
Besseau-Ayasse, J., Violle-Poirsier, C., Bazin, A., Gruchy, N., Moncla, A., Girard, F., et al. (2014). A French collaborative survey of 272 fetuses with 22q11.2 deletion: ultrasound findings, fetal autopsies and pregnancy outcomes. Prenatal Diagnosis, 34(5), 424–430.
Bretelle, F., Beyer, L., Pellissier, M. C., Missirian, C., Sigaudy, S., Gamerre, M., et al. (2010). Prenatal and postnatal diagnosis of 22q11.2 deletion syndrome. European Journal of Medical Genetics, 53(6), 367–370.
Butcher, N., Chow, E., Costain, G., Karas, D., Ho, A., & Bassett, A. (2012). Functional outcomes of adults with 22q11.2 deletion syndrome. Genetics in Medicine, 14(10), 836–843.
Cheung, E. N., George, S. R., Andrade, D. M., Chow, E. W., Silversides, C. K., & Bassett, A. S. (2014a). Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genetics in Medicine, 16(1), 40–44.
Cheung, E. N., George, S. R., Costain, G. A., Andrade, D. M., Chow, E. W., Silversides, C. K., et al. (2014b). Prevalence of hypocalcemia and its associated features in 22q11.2 deletion syndrome. Clinical Endocrinology, 81(2), 190–196.
Chow, E. W., Watson, M., Young, D. A., & Bassett, A. S. (2006). Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophrenia Research, 87(1–3), 270–278.
Cirillo, E., Giardino, G., Gallo, V., Puliafito, P., Azzari, C., Bacchetta, R., et al. (2014). Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects. BMC Medical Genetics, 15(1), 1.
Costain, G., Chow, E. W., Silversides, C. K., & Bassett, A. S. (2011). Sex differences in reproductive fitness contribute to preferential maternal transmission of 22q11.2 deletions. Journal of Medical Genetics, 48(12), 819–824.
Costain, G., Chow, E. W., Ray, P. N., & Bassett, A. S. (2012). Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. Journal of Intellectual Disability Research, 56(6), 641–651.
Costain, G., McDonald-McGinn, D. M., & Bassett, A. S. (2013). Prenatal genetic testing with chromosomal microarray analysis identifies major risk variants for schizophrenia and other later-onset disorders. American Journal of Psychiatry, 170(12), 1498.
Devriendt, K., Moerman, P., Van Schoubroeck, D., Vandenberghe, K., & Fryns, J. P. (1997). Chromosome 22q11 deletion presenting as the Potter sequence. Journal of Medical Genetics, 34(5), 423–425.
Dunlop, S., Coyte, P. C., & McIsaac, W. (2000). Socio-economic status and the utilisation of physicians’ services: results from the Canadian national population health survey. Social Science and Medicine, 51(1), 123–133.
Fantasia, H. C., & Fontenot, H. B. (2011). The sexual safety of adolescents. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 40(2), 217–224.
Finucane, B. (2010). Genetic counseling for women with intellectual disabilities. In B. S. LeRoy, P. M. Veach, & D. M. Bartels (Eds.), Genetic Counseling Practice: Advanced Concepts and Skills. Hoboken: Wiley-Blackwell.
Fisher, W., Boroditsky, R., & Morris, B. (2004). The 2002 Canadian contraception study: part 2. Journal of Obstetrics and Gynaecology Canada, 26(7), 646–656.
Fung, W. L., Chow, E. W., Webb, G. D., Gatzoulis, M. A., & Bassett, A. S. (2008). Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease. International Journal of Cardiology, 131(1), 51–58.
Fung, W. L., McEvilly, R., Fong, J., Silversides, C., Chow, E., & Bassett, A. (2010). Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. American Journal of Psychiatry, 167(8), 998.
Garcia-Enguindanos, A., Calle, M. E., Valero, J., Luna, S., & Dominquez-Rojas, V. (2002). Risk factors in miscarriage: a review. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 102(2), 111–119.
Goodship, J., Cross, I., LiLing, J., & Wren, C. (1998). A population study of chromosome 22q11 deletions in infancy. Archives of Disease in Childhood, 79(4), 348–351.
Greenhalgh, K. L., Aligianis, I. A., Bromilow, G., Cox, H., Hill, C., Stait, Y., et al. (2003). 22q11 deletion: a multisystem disorder requiring multidisciplinary input. Archives of Disease in Childhood, 88(6), 523–524.
Hatton, R., Colman, J. M., Sermer, M., Grewal, J., & Silversides, C. K. (2012). Cardiac risks and management of complications in pregnant women with congenital heart disease. Future Cardiology, 8(2), 315–327.
Health Canada. (2003). Canadian Perinatal Health Report, 2003. Ottawa: Minister of Public Works and Government Services Canada.
Ho, J. S., Radoeva, P. D., Jalbrzikowski, M., Chow, C., Hopkins, J., Tran, W. C., et al. (2012). Deficits in mental state attributions in individuals with 22q11.2 deletion syndrome (velo-cardio-facial syndrome). Autism Research : Official Journal of the International Society for Autism Research, 5(6), 407–418.
Jablensky, A. V., Morgan, V., Zubrick, S. R., Bower, C., & Yellachich, L. A. (2005). Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. American Journal of Psychiatry, 162(1), 79–91.
Kaminsky, E. B., Kaul, V., Paschall, J., Church, D. M., Bunke, B., Kunig, D., et al. (2011). An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genetics in Medicine, 13(9), 777–784.
Kapadia, R. K., & Bassett, A. S. (2008). Recognizing a common genetic syndrome: 22q11.2 deletion syndrome. Canadian Medical Association Journal, 178(4), 391–393.
Karas, D. J., Costain, G., Chow, E. W., & Bassett, A. S. (2014). Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome. Journal of Intellectual Disability Research, 58(2), 198–210.
Kirkham, C., Harris, S., & Grzybowski, S. (2005). Evidence-based prenatal care: part I. General prenatal care and counseling issues. American Family Physician, 71(7), 1307–1316.
Kramer, M. S., Platt, R. W., Wen, S. W., Joseph, K. S., Allen, A., Abrahamowicz, M., et al. (2001). A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics, 108(2), E35.
Lowther, C., Costain, G., Stavropoulos, D. J., Melvin, R., Silversides, C. K., Andrade, D. M., et al. (2014). Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature. Genet Med. doi:https://doi.org/10.1038/gim.2014.83.
McConnell, D., Mayes, R., & Llewellyn, G. (2008). Women with intellectual disability at risk of adverse pregnancy and birth outcomes. Journal of Intellectual Disability Research, 52(Pt 6), 529–535.
McDonald-McGinn, D., & Sullivan, K. (2011). Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine, 90(1), 1–18.
McDonald-McGinn, D. M., & Zackai, E. H. (2008). Genetic counseling for the 22q11.2 deletion. Developmental Disabilities Research Reviews, 14(1), 69–74.
McDonald-McGinn, D. M., Tonnesen, M. K., Laufer-Cahana, A., Finucane, B., Driscoll, D. A., Emanuel, B. S., et al. (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genetics in Medicine, 3(1), 23–29.
Monteiro, F. P., Vieira, T. P., Sgardioli, I. C., Molck, M. C., Damiano, A. P., Souza, J., et al. (2013). Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature. European Journal of Pediatrics, 172(7), 927–945.
Moos, M. K., Dunlop, A. L., Jack, B. W., Nelson, L., Coonrod, D. V., Long, R., et al. (2008). Healthier women, healthier reproductive outcomes: recommendations for the routine care of all women of reproductive age. American Journal of Obstetrics and Gynecology, 199(6 Suppl 2), S280–S289.
Negro, R., & Mestman, J. H. (2011). Thyroid disease in pregnancy. Best Practice & Research. Clinical Endocrinology & Metabolism, 25(6), 927–943.
Nordeng, H., Ystrom, E., & Einarson, A. (2010). Perception of risk regarding the use of medications and other exposures during pregnancy. European Journal of Clinical Pharmacology, 66(2), 207–214.
Oh, D. C., Min, J. Y., Lee, M. H., Kim, Y. M., Park, S. Y., Won, H. S., et al. (2002). Prenatal diagnosis of tetralogy of Fallot associated with chromosome 22q11 deletion. Journal of Korean Medical Science, 17(1), 125–128.
Parkes, I., Schenker, J. G., & Shufaro, Y. (2013). Parathyroid and calcium metabolism disorders during pregnancy. Gynecological Endocrinology, 29(6), 515–519.
Patel, Z. M., Gawde, H. M., & Khatkhatay, M. I. (2006). 22q11 microdeletion studies in the heart tissue of an abortus involving a familial form of congenital heart disease. Journal of Clinical Laboratory Analysis, 20(4), 160–163.
Patton, M. A., & Afzal, A. R. (2002). Robinow syndrome. Journal of Medical Genetics, 39(5), 305–310.
Ramos, G. A., Chopra, I. J., & Bales, S. R. (2012). Endocrine disorders in pregnancy. In P. J. Di Saia, G. Chaudhuri, L. C. Guidice, T. R. Moore, M. Porto, & L. H. Smith (Eds.), Women’s Health Review: A Clinical Update in Obstetrics-Gynecology (pp. 226–234). Philadelphia: Elsevier Saunders.
Rasiah, S. V., Publicover, M., Ewer, A. K., Khan, K. S., Kilby, M. D., & Zamora, J. (2006). A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound in Obstetrics and Gynecology, 28(1), 110–116.
Schneider, M., Debbané, M., Bassett, A. S., Chow, E. W. C., Fung, W. L. A., Van den Bree, M. B. M., et al. (2014). Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. American Journal of Psychiatry, 171(6), 627–639.
Seeman, M. V. (2013). Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatrica Scandinavica, 127(1), 12–22.
Servais, L., Jacques, D., Leach, R., Conod, L., Hoyois, P., Dan, B., et al. (2002). Contraception of women with intellectual disability: prevalence and determinants. Journal of Intellectual Disability Research, 46(Pt 2), 108–119.
Taylor, M. R., Edwards, J. G., & Ku, L. (2006). Lost in transition: challenges in the expanding field of adult genetics. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 142C(4), 294–303.
Thorne, S. A. (2004). Pregnancy in heart disease. Heart, 90(4), 450–456.
Vissenberg, R., van den Boogaard, E., van Wely, M., Van der Post, J. A., Fliers, E., Bisschop, P. H., et al. (2012). Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Human Reproduction Update, 18(4), 360–373.
Wou, K., Ouellet, M. P., Chen, M. F., & Brown, R. N. (2014). Comparison of the aetiology of stillbirth over five decades in a single centre: a retrospective study. BMJ Open, 4(6), e004635.
The authors thank the adults with 22q11.2DS and their families for their generous contributions to this and related research studies. The authors express gratitude to the students, research assistants, and staff affiliated with the Clinical Genetics Research Program, Clinical Genetics Service, and Toronto Congenital Cardiac Centre for Adults (TCCCA). Special thanks go to Fiona Fu, Lisa Palmer, and Monica Torsan. This work was supported by Canadian Institutes of Health Research (CIHR) grants (MOP-97800 and MOP-89066), MD/PhD studentships from CIHR and the McLaughlin Centre (to Gregory Costain), and an award from the Mach-Gaensslen Foundation administered through the Comprehensive Research Experience for Medical Students (CREMS) summer research program (to Chrystal Chan). Anne S. Bassett holds the Canada Research Chair in Schizophrenia Genetics and Genomic Disorders, and the Dalglish Chair in 22q11.2 Deletion Syndrome.
Conflict of Interest Statements
Chrystal Chan, Gregory Costain, Lucas Ogura, Candice K. Silversides, Eva W.C. Chow, and Anne S. Bassett declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
No animal studies were carried out by the authors for this article.
About this article
Cite this article
Chan, C., Costain, G., Ogura, L. et al. Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome. J Genet Counsel 24, 810–821 (2015). https://doi.org/10.1007/s10897-014-9811-7
- DiGeorge syndrome
- Velocardiofacial syndrome
- Prenatal testing
- Pregnancy complications
- Genomic disorder